BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 28329576)

  • 1. 5-Fluorouracil-induced exacerbation of rosacea.
    Haddock ES; Cohen PR
    Dermatol Online J; 2016 Nov; 22(11):. PubMed ID: 28329576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical 5-fluorouracil for the treatment of periocular actinic keratosis and low-grade squamous malignancy.
    Couch SM; Custer PL
    Ophthalmic Plast Reconstr Surg; 2012; 28(3):181-3. PubMed ID: 22460673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective randomized exploratory study comparing the efficacy of once-daily topical 0.5% 5-fluorouracil in combination with 10.0% salicylic acid (5-FU/SA) vs. cryosurgery for the treatment of hyperkeratotic actinic keratosis.
    Simon JC; Dominicus R; Karl L; Rodríguez R; Willers C; Dirschka T
    J Eur Acad Dermatol Venereol; 2015 May; 29(5):881-9. PubMed ID: 25257941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy and safety of topical 5% 5-fluorouracil in renal transplant recipients for the treatment of actinic keratoses.
    Ingham AI; Weightman W
    Australas J Dermatol; 2014 Aug; 55(3):204-8. PubMed ID: 24627952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of topical 5-fluorouracil formulations in actinic keratosis treatment.
    Kaur RR; Alikhan A; Maibach HI
    J Dermatolog Treat; 2010 Sep; 21(5):267-71. PubMed ID: 19878034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose 5-fluorouracil in combination with salicylic acid as a new lesion-directed option to treat topically actinic keratoses: histological and clinical study results.
    Stockfleth E; Kerl H; Zwingers T; Willers C
    Br J Dermatol; 2011 Nov; 165(5):1101-8. PubMed ID: 21517801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical application of 5-fluorouracil 5 percent cream associated with severe neutropenia: discussion of a case and review of systemic reactions after topical treatment with 5-fluorouracil.
    Cohen PR
    Dermatol Online J; 2018 Apr; 24(4):. PubMed ID: 29906006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Painful scrotal dermatitis secondary to topical 5-fluorouracil.
    Yi JZ; Himes RS; Smith RJ; McKee PH; Roberts AA
    Dermatol Online J; 2021 Jun; 27(6):. PubMed ID: 34387061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symmetrical drug-related intertriginous and flexural exanthema secondary to topical 5-fluorouracil.
    Powers R; Gordon R; Roberts K; Kovach R
    Cutis; 2012 May; 89(5):225-8. PubMed ID: 22768435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-Dose 0.5% 5-Fluorouracil/10% Salicylic Acid Topical Solution in the Treatment of Actinic Keratoses.
    Herranz P; Morton C; Dirschka T; Azeredo RR; Roldán-Marín R
    J Cutan Med Surg; 2016 Nov; 20(6):555-561. PubMed ID: 27443886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy, Safety, and Tolerability of 4% 5-Fluorouracil Cream in a Novel Patented Aqueous Cream Containing Peanut Oil Once Daily Compared With 5% 5-Fluorouracil Cream Twice Daily: Meeting the Challenge in the Treatment of Actinic Keratosis.
    Dohil MA
    J Drugs Dermatol; 2016 Oct; 15(10):1218-1224. PubMed ID: 27741339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of Photograph-Based Toxicity Score for Topical 5-Fluorouracil Cream Application.
    Pomerantz H; Korgavkar K; Lee KC; Lew R; Weinstock MA;
    J Cutan Med Surg; 2016 Sep; 20(5):458-66. PubMed ID: 27207349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensified inflammatory reaction of actinic keratoses after single application of topical 5-fluorouracil in a patient treated with nilotinib for chronic myeloid leukemia.
    Schmid-Wendtner MH; Wendtner CM
    Dermatology; 2009; 219(4):341-3. PubMed ID: 19468201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomised study of topical 5% imiquimod vs. topical 5-fluorouracil vs. cryosurgery in immunocompetent patients with actinic keratoses: a comparison of clinical and histological outcomes including 1-year follow-up.
    Krawtchenko N; Roewert-Huber J; Ulrich M; Mann I; Sterry W; Stockfleth E
    Br J Dermatol; 2007 Dec; 157 Suppl 2():34-40. PubMed ID: 18067630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence to a topical regimen of 5-fluorouracil, 0.5%, cream for the treatment of actinic keratoses.
    Yentzer B; Hick J; Williams L; Inabinet R; Wilson R; Camacho FT; Russell GB; Feldman SR
    Arch Dermatol; 2009 Feb; 145(2):203-5. PubMed ID: 19221274
    [No Abstract]   [Full Text] [Related]  

  • 16. Topical fluorouracil for actinic keratoses and photoaging: a clinical and molecular analysis.
    Sachs DL; Kang S; Hammerberg C; Helfrich Y; Karimipour D; Orringer J; Johnson T; Hamilton TA; Fisher G; Voorhees JJ
    Arch Dermatol; 2009 Jun; 145(6):659-66. PubMed ID: 19528421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Actinic Keratoses: A Randomized Split-Site Approach Comparison of Sequential 5-Fluorouracil and 5-Aminolevulinic Acid Photodynamic Therapy to 5-Aminolevulinic Acid Photodynamic Monotherapy.
    Pei S; Kaminska ECN; Tsoukas MM
    Dermatol Surg; 2017 Sep; 43(9):1170-1175. PubMed ID: 28562434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Actikerall™ (5-Fluorouracil 0.5% and Salicylic Acid 10%) Topical Solution for Patient-directed Treatment of Actinic Keratoses.
    Nguyen HP; Rivers JK
    Skin Therapy Lett; 2016 May; 21(3):1-3. PubMed ID: 27223248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized trial of calcipotriol combined with 5-fluorouracil for skin cancer precursor immunotherapy.
    Cunningham TJ; Tabacchi M; Eliane JP; Tuchayi SM; Manivasagam S; Mirzaalian H; Turkoz A; Kopan R; Schaffer A; Saavedra AP; Wallendorf M; Cornelius LA; Demehri S
    J Clin Invest; 2017 Jan; 127(1):106-116. PubMed ID: 27869649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical treatment of actinic keratoses with low-dose 5-fluorouracil in combination with salicylic acid--pilot study.
    Schlaak M; Simon JC
    J Dtsch Dermatol Ges; 2010 Mar; 8(3):174-8. PubMed ID: 19889001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.